Contact Lenses
LID022821/AOHP for Refractive Errors
N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upweek 1, each study lens type
Awards & highlights
No Placebo-Only Group
Study Summary
This trial tests how two contact lenses work for daily wear for people who need them.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1, each study lens type
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, each study lens type
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Distance VA with study lenses at Week 1
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: LID022821/AOHPExperimental Treatment3 Interventions
Serafilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE will be used for daily cleaning and disinfection.
Group II: AOHP/LID022821Experimental Treatment3 Interventions
Senofilcon A contact lenses worn first, with serafilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE will be used for daily cleaning and disinfection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Senofilcon A contact lenses
2022
N/A
~1790
CLEAR CARE
2022
N/A
~1470
Serafilcon A contact lenses
2022
N/A
~260
Find a site
Who is running the clinical trial?
Alcon ResearchLead Sponsor
693 Previous Clinical Trials
122,325 Total Patients Enrolled
98 Trials studying Refractive Errors
11,535 Patients Enrolled for Refractive Errors
Clinical Trial Lead Alcon Vision CareStudy Director
Alcon Research, LLCFrequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.